Literature DB >> 2189550

The control of growth and differentiation in normal and leukemic blood cells.

L Sachs1.   

Abstract

The establishment of a cell culture system for the clonal development of hematopoietic cells has made it possible to discover the proteins that control growth and differentiation of different hematopoietic cell lineages and the molecular basis of normal and abnormal cell development in blood-forming tissues. A model system with myeloid cells has shown that normal hematopoietic cells require different proteins to induce cell multiplication and cell differentiation, and that a cascade of interactions between proteins determines the correct balance between immature and mature cells in normal development. Gene cloning has shown that there is a family of different genes for these proteins. Normal protein regulators of hematopoiesis can control the abnormal growth of certain types of leukemic cells and suppress malignancy by inducing differentiation to mature nondividing cells. Genetic abnormalities that give rise to malignancy in these leukemic cells can be bypassed and their effects nullified by inducing differentiation, which stops cells from multiplying. These hematopoietic regulatory proteins are active in culture and in vivo and have been used clinically to correct defects in blood cell development. The results provide new approaches to therapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2189550     DOI: 10.1002/1097-0142(19900515)65:10<2196::aid-cncr2820651006>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

Review 1.  The discovery, development and clinical applications of granulocyte colony-stimulating factor.

Authors:  D C Dale
Journal:  Trans Am Clin Climatol Assoc       Date:  1998

2.  Cytokine production by a megakaryocytic cell line.

Authors:  B Sandrock; K M Hudson; D E Williams; M A Lieberman
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-04       Impact factor: 2.416

3.  The Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myeloid cell differentiation.

Authors:  B Tong; H L Grimes; T Y Yang; S E Bear; Z Qin; K Du; W S El-Deiry; P N Tsichlis
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

4.  Pioneer of hematopoietic colony-stimulating factors: Leo Sachs (1924-2013).

Authors:  Michael Sela; Yoram Groner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

5.  p53-mediated cell death: relationship to cell cycle control.

Authors:  E Yonish-Rouach; D Grunwald; S Wilder; A Kimchi; E May; J J Lawrence; P May; M Oren
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

6.  The scientific bases of cancer management: at the interface between fundamental research and clinical practice.

Authors:  M Tubiana
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

7.  Towards a systemic paradigm in carcinogenesis: linking epigenetics and genetics.

Authors:  Ernesto Burgio; Lucia Migliore
Journal:  Mol Biol Rep       Date:  2015-04       Impact factor: 2.316

Review 8.  Expression genetics in cancer: shifting the focus from DNA to RNA.

Authors:  R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

Review 9.  The control of hematopoiesis and leukemia: from basic biology to the clinic.

Authors:  L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

10.  Cloning and antisense oligodeoxynucleotide inhibition of a human homolog of cdc2 required in hematopoiesis.

Authors:  Y Lapidot-Lifson; D Patinkin; C A Prody; G Ehrlich; S Seidman; R Ben-Aziz; F Benseler; F Eckstein; H Zakut; H Soreq
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.